≡

Complement 1 Inhibitor (C1INH)

[Edit]

SERPING1; C1IN; C1-INH; C1NH; HAE1; HAE2; Serpin Peptidase Inhibitor Clade G Member 1; Angioedema Hereditary; C1 Inhibitor; C1 Esterase Inhibitor

Complement 1 Inhibitor (C1INH)
CCC A235
HGNC 1228
MGI 894696
PubMed 22882460
RGD 735225
UniProt P05155

C1-INH is a critically important protein that controls activation of multiple plasma mediator pathways. This protein, a member of the serine protease inhibitor (serpin) group, originally was described as an inhibitor of C1. It binds stoichiometrically to the active sites on both C1r and C1s to form a complex C1-INH-C1r-C1s-C1-INH and thus inhibits activated C1. In addition, C1-INH has been reported to remove the intact C1qrs complex from an activating surface and to inhibit autoactivation of C1. C1-INH is a known inhibitor of kinin generating (kallikrein), fibrinolytic (plasmin), and contact activation (intrinsic) pathway of the coagulation cascade. Recently, it has been shown to be an inhibitor of the mannan-binding lectin pathway of complement activation, inhibiting mannan-binding lectin-associated serine proteases (MASPs) in that pathway.

 

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA235Hu01 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Hu02 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA235Hu01 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
MAA235Hu22 Monoclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
LAA235Hu71 Biotin-Linked Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC.
LAA235Hu81 FITC-Linked Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IF.
MAA235Hu21 Monoclonal Antibody to Complement 1 Inhibitor (C1INH) WB
LAA235Hu72 Biotin-Linked Monoclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC.
PAA235Hu02 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
MAA235Hu23 Monoclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
Assay Kits SEA235Hu ELISA Kit for Complement 1 Inhibitor (C1INH) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA235Hu CLIA Kit for Complement 1 Inhibitor (C1INH) Chemiluminescent immunoassay for Antigen Detection.

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA235Mu01 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Mu02 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Mu03 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Mu04 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Mu05 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Mu06 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Mu07 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Mu08 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA235Mu01 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
PAA235Mu03 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
PAA235Mu02 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
LAA235Mu71 Biotin-Linked Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC.
LAA235Mu81 FITC-Linked Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IF.
PAA235Mu04 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
PAA235Mu05 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
Assay Kits SEA235Mu ELISA Kit for Complement 1 Inhibitor (C1INH) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA235Ra01 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
RPA235Ra02 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
EPA235Ra61 Eukaryotic Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA235Ra01 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
PAA235Ra02 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
LAA235Ra71 Biotin-Linked Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC.
LAA235Ra81 FITC-Linked Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IF.
Assay Kits SEA235Ra ELISA Kit for Complement 1 Inhibitor (C1INH) Enzyme-linked immunosorbent assay for Antigen Detection.

Organism species: Oryctolagus cuniculus (Rabbit)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA235Rb01 Recombinant Complement 1 Inhibitor (C1INH) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA235Rb51 Polyclonal Antibody to Complement 1 Inhibitor (C1INH) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Complement 1 Inhibitor (C1INH) CLIA Kit Customized Service Offer
n/a ELISA Kit for Complement 1 Inhibitor (C1INH) ELISA Kit Customized Service Offer
  1. "Isolation and analysis of a cDNA coding for human C1 inhibitor."Biochem. Biophys. Res. Commun. 137:620-625(1986) [PubMed] [Europe PMC] [Abstract]
  2. "Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization."Biochemistry 25:4292-4301(1986) [PubMed] [Europe PMC] [Abstract]
  3. "Genomic and cDNA cloning of the human C1 inhibitor. Intron-exon junctions and comparison with other serpins."Eur. J. Biochem. 173:163-169(1988) [PubMed] [Europe PMC] [Abstract]
  4. "Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements."Eur. J. Biochem. 197:301-308(1991) [PubMed] [Europe PMC] [Abstract]
  5. "Complete sequencing and characterization of 21,243 full-length human cDNAs." Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Human chromosome 11 DNA sequence and analysis including novel gene identification." Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract]
  7. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  8. "Molecular cloning of the cDNA coding for human C1 inhibitor."Protein Seq. Data Anal. 1:251-257(1988) [PubMed] [Europe PMC] [Abstract]
  9. "The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant."J. Biol. Chem. 278:29463-29470(2003) [PubMed] [Europe PMC] [Abstract]
  10. "Human C1 inhibitor: improved isolation and preliminary structural characterization."Biochemistry 22:5001-5007(1983) [PubMed] [Europe PMC] [Abstract]
  11. "Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements."Proc. Natl. Acad. Sci. U.S.A. 87:1551-1555(1990) [PubMed] [Europe PMC] [Abstract]
  12. "Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily."Gene 42:265-272(1986) [PubMed] [Europe PMC] [Abstract]
  13. "Molecular weights and isoelectric points of sperm antigens relevant to autoimmune infertility in men."J. Urol. 155:1928-1933(1996) [PubMed] [Europe PMC] [Abstract]
  14. "Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11."Proc. Natl. Acad. Sci. U.S.A. 83:3161-3165(1986) [PubMed] [Europe PMC] [Abstract]
  15. "Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function."J. Clin. Invest. 95:350-359(1995) [PubMed] [Europe PMC] [Abstract]
  16. "Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers."Protein Sci. 2:727-732(1993) [PubMed] [Europe PMC] [Abstract]
  17. "Proteolytic activities of two types of mannose-binding lectin-associated serine protease."J. Immunol. 165:2637-2642(2000) [PubMed] [Europe PMC] [Abstract]
  18. "StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor."Mol. Microbiol. 45:277-288(2002) [PubMed] [Europe PMC] [Abstract]
  19. "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry."Nat. Biotechnol. 21:660-666(2003) [PubMed] [Europe PMC] [Abstract]
  20. "Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7."J. Exp. Med. 199:1077-1087(2004) [PubMed] [Europe PMC] [Abstract]
  21. "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry."Proteomics 4:454-465(2004) [PubMed] [Europe PMC] [Abstract]
  22. "N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A."Infect. Immun. 73:4478-4487(2005) [PubMed] [Europe PMC] [Abstract]
  23. "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
  24. "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."J. Proteome Res. 8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
  25. "A strategy for precise and large scale identification of core fucosylated glycoproteins."Mol. Cell. Proteomics 8:913-923(2009) [PubMed] [Europe PMC] [Abstract]
  26. "Enrichment of glycopeptides for glycan structure and attachment site identification."Nat. Methods 6:809-811(2009) [PubMed] [Europe PMC] [Abstract]
  27. "Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD."Mol. Cell. Proteomics 0:0-0(2011) [PubMed] [Europe PMC] [Abstract]
  28. "LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins."J. Proteome Res. 12:573-584(2013) [PubMed] [Europe PMC] [Abstract]
  29. "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]
  30. "C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease."J. Biol. Chem. 282:21100-21109(2007) [PubMed] [Europe PMC] [Abstract]
  31. "What do dysfunctional serpins tell us about molecular mobility and disease?"Nat. Struct. Biol. 2:96-113(1995) [PubMed] [Europe PMC] [Abstract]
  32. "Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444-->His) mutation."Biochem. J. 253:615-618(1988) [PubMed] [Europe PMC] [Abstract]
  33. "Identification of a new P1 residue mutation (444Arg-->Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasma."FEBS Lett. 266:13-16(1990) [PubMed] [Europe PMC] [Abstract]
  34. "Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene."Proc. Natl. Acad. Sci. U.S.A. 87:265-268(1990) [PubMed] [Europe PMC] [Abstract]
  35. "Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site."Proc. Natl. Acad. Sci. U.S.A. 87:6786-6790(1990) [PubMed] [Europe PMC] [Abstract]
  36. "Identification of type II hereditary angio-oedema (HAE) mutations."Clin. Exp. Immunol. 86:11-12(1991)
  37. "A dysfunctional C1 inhibitor protein with a new reactive center mutation (Arg-444-->Leu)."FEBS Lett. 301:34-36(1992) [PubMed] [Europe PMC] [Abstract]
  38. "C1 inhibitor hinge region mutations produce dysfunction by different mechanisms."Nat. Genet. 1:354-358(1992) [PubMed] [Europe PMC] [Abstract]
  39. "Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema."Behring Inst. Mitt. 93:313-320(1993) [PubMed] [Europe PMC] [Abstract]
  40. "Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein."J. Clin. Invest. 95:1299-1305(1995) [PubMed] [Europe PMC] [Abstract]
  41. "A mutation unique in serine protease inhibitors (serpins) identified in a family with type II hereditary angioneurotic edema."Mol. Med. 1:700-705(1995) [PubMed] [Europe PMC] [Abstract]
  42. "Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema."Am. J. Hum. Genet. 59:308-319(1996) [PubMed] [Europe PMC] [Abstract]
  43. "Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema."Hum. Mutat. 22:498-498(2003) [PubMed] [Europe PMC] [Abstract]
  44. "Normal C1 inhibitor mRNA expression level in type I hereditary angioedema patients: newly found C1 inhibitor gene mutations."Allergy 61:260-264(2006) [PubMed] [Europe PMC] [Abstract]
  45. "Mutational spectrum and geno-phenotype correlation in Chinese families with Hereditary Angioedema."Allergy 67:1430-1436(2012) [PubMed] [Europe PMC] [Abstract]
  46. "Mutational spectrum of the c1 inhibitor gene in a cohort of Italian patients with hereditary angioedema: description of nine novel mutations."Ann. Hum. Genet. 78:73-82(2014) [PubMed] [Europe PMC] [Abstract]